Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-04-13
1985-11-05
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514234, 514236, A61K 31505, A61K 2700
Patent
active
045514593
ABSTRACT:
Compounds according to the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof wherein: n is an integer of 1 to 6;
REFERENCES:
patent: 3932407 (1976-01-01), Bevering et al.
patent: 4070470 (1978-01-01), Nakagawa et al.
patent: 4256748 (1981-03-01), Chodnekar et al.
patent: 4313947 (1982-02-01), Nakagawa et al.
Alvarez Robert
Bruno John J.
Jones Gordon H.
Venuti Michael C.
Kanagy James M.
Moran Tom M.
Robinson Douglas W.
Syntex (U.S.A.) Inc.
LandOfFree
Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-296099